China NMPA Product Recall - Nano Acupoint Patch

Chongqing Yixintang Trading Co., Ltd. initiated a voluntary Level III recall for its Nano Acupoint Patches, publicly announced on April 12, 2021, under the guidance of China's National Medical Products Administration (NMPA) and the local Chongqing Municipal Drug Administration. The primary reasons for this recall stemmed from identified issues with product labeling, alongside other unspecified concerns. The affected medical device, registered under the number 渝食药监械（准）字2014第1260098号, requires removal from the market to address these non-conformities. A Level III recall, as designated by regulatory authorities, indicates that while the product may have minor deviations or issues, its use is unlikely to cause adverse health consequences to consumers. Nevertheless, such actions are crucial for maintaining regulatory compliance and ensuring product quality standards. The company provided a "Medical Device Recall Event Report Form" with comprehensive details on the specific models, specifications, and batch numbers of the recalled patches. This voluntary action by Chongqing Yixintang Trading Co., Ltd. underscores the company's commitment to adhering to stringent national medical device regulations and prioritizing consumer safety. It demonstrates the NMPA's robust framework for monitoring and ensuring the integrity of medical products available to the public, requiring companies to take prompt corrective measures when issues arise.